Type 2 Diabetes With Antiplatelet Drugs
Condition(s):Type2 Diabetes; Antiplatelet Drugs; Myocardial Infarction; Heart FailureLast Updated:January 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Type2 Diabetes; Antiplatelet Drugs; Myocardial Infarction; Heart FailureLast Updated:January 31, 2023Completed
Condition(s):Antiplatelet Drug-related Gastrointestinal InjuryLast Updated:October 31, 2018Unknown status
Condition(s):Ischemic Heart Disease; Acute Coronary SyndromeLast Updated:September 25, 2023Recruiting
Condition(s):Coronary Artery Disease; Coronary Artery StenosisLast Updated:February 28, 2024Active, not recruiting
Condition(s):DiabetesLast Updated:July 24, 2019Withdrawn
Condition(s):Anticoagulant Drugs; Antiplatelet Drug; Peripheral Arterial DiseaseLast Updated:May 10, 2023Recruiting
Condition(s):Cardiac Arrest; Myocardial Infarction; Extracorporeal Membrane Oxygenation; Platelet DysfunctionLast Updated:February 15, 2023Recruiting
Condition(s):Renal Failure; Coronary Artery Disease; HemolysisLast Updated:January 8, 2018Unknown status
Condition(s):Cerebral HemorrhageLast Updated:May 9, 2022Terminated
Condition(s):Ischemic Stroke; Antiplatelet EffectLast Updated:October 29, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.